Because canonical full-length METTL3-A regulates the carcinogenesis, tumor progression, and drug resistance of HCC [31,46], we carefully detected the levels of METTL3 splicing variants in normal human liver, HCC tumor tissues, and HepG2 cells using RT-qPCR. Here, METTL3 is linked to hepatocellular carcinoma.